Categories: HospitalsNews

vopemed Secures $2.29M CAD Pre-Seed Funding to Redefine Surgical Visualization with AI

MONTRÉAL, April 2, 2025 /PRNewswire/ – vopemed (Vope Medical), a pioneering MedTech startup enhancing surgical vision with AI-powered image clarification, has secured an oversubscribed $2.29 million pre-seed funding round to accelerate the development and clinical validation of its technology. This funding marks a significant milestone in vopemed’s vision of empowering surgical teams with next-generation tools for safer, more efficient surgeries.

vopemed is developing Claris, an AI-driven image enhancement software designed to improve the clarity of laparoscopic and robotic-assisted procedure video feeds in real-time, leading to safer surgeries.

“This funding validates the need for enhanced surgical visualization and reinforces our mission to bring AI-powered image enhancement into every operating room,” said Amy Lorincz, CEO and co-founder of vopemed. “Current solutions fail to address persistent visibility challenges in minimally invasive surgery, and Claris is designed to solve this unmet need.”

“We are excited to support vopemed as they bring AI-driven image enhancement to surgery,” said Jacques Courtois of Genson Capital Inc. “Their technology has the potential to significantly improve surgical precision and efficiency, and we believe they are well-positioned to make a lasting impact in MedTech.”

“Clear visualization is critical for precise surgical decisions, especially in minimally invasive procedures. AI-driven image enhancement like Claris could be a game-changer in improving efficiency and patient outcomes,” said Dr. Dicken Ko, Urologic Surgeon, Professor of Surgery at The Warren Alpert Medical School of Brown University.

The pre-seed round was led by Genson Capital Inc., which invested $1.5 million CAD, and Investissement Québec, as a mandated agent of the gouvernement du Québec, which contributed $750,000 CAD. These investors bring valuable support to life science and medical device companies, enabling them to advance innovation and scale in a regulated industry.

With the funds secured, vopemed will expand R&D, refine its software for broader clinical applications, and strengthen partnerships with hospitals and surgical teams. The company is also preparing for clinical validation studies to further demonstrate Claris’ impact in real-world settings.

About vopemed
vopemed is a MedTech startup dedicated to enhancing surgical vision with AI-powered image clarification technology. Its flagship product, Claris, integrates seamlessly with existing surgical systems to provide real-time, high-clarity imaging, reducing visual obstructions and improving visualization in minimally invasive surgery. The company is committed to redefining surgery by equipping surgical teams with cutting-edge tools for safer, more efficient procedures.

View original content to download multimedia:https://www.prnewswire.com/news-releases/vopemed-secures-2-29m-cad-pre-seed-funding-to-redefine-surgical-visualization-with-ai-302417771.html

SOURCE vopemed

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

2 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

2 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

1 day ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

1 day ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

1 day ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

1 day ago